[Nephrology 2007].
Hugo
C
C
Medizinische Klinik 4, Universität Erlangen-Nürnberg, Erlangen, Germany. christian.hugo@rzmail.uni-erlangen.de
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D002318:Cardiovascular Diseases / Q000453:epidemiology* / Q000209:etiology; D005682:Gadolinium / Q000009:adverse effects*; D005858:Germany / Q000453:epidemiology; D005919:Glomerular Filtration Rate; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D052177:Kidney Diseases, Cystic / Q000139:chemically induced* / Q000188:drug therapy; D016030:Kidney Transplantation; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D011379:Prognosis; D006435:Renal Dialysis / Q000379:methods*; D051437:Renal Insufficiency / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D012307:Risk Factors; D012720:Severity of Illness Index
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D006454:Hemoglobins; D000451:Mineralocorticoid Receptor Antagonists; D005682:Gadolinium